Medtronic plc — Director's Dealing 2023

Aug 8, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2023-08-03

Reporting Person: Marinaro Michael (EVP & President, Surgical OU)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-08-03	Ordinary Shares	A	1696	—	Acquired	31605	Direct
2023-08-03	Ordinary Shares	F	1323	$84.49	Disposed	30282	Direct
2023-08-04	Ordinary Shares	S	1352	$84.11	Disposed	28930	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-08-03	Performance Share Unit	$	M	1696	Disposed		Performance Share Units (1696)	Direct

Footnotes

F1: Represents shares issued upon the settlement of performance-vesting restricted stock units granted on October 9, 2020 and earned dividend equivalents.

F2: Includes 19 shares representing earned dividend equivalents upon the settlement of restricted stock units that vested on August 3, 2023 and were previously reported on Table 1.

F3: Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units and restricted stock units that vested on August 3, 2023.

F4: This transaction was made pursuant to Mr. Marinaro's existing Rule 10b5-1 plan.

F5: Each performance share unit represented a contingent right to receive one share of Medtronic common stock.

F6: The performance share units vested on August 3, 2023.